Presentation ESC 2022 Colchicine and Aspirin in Community Patients with COVID-19: An Open-label, Factorial, Randomized Trial Presenter: John Eikelboom August 29, 2022 REGISTER for free or LOG IN to view this content COVID-19 Clinical Pharma Presentation ESC 2022 Up Next Presentation ESC 2022 A Polypill Strategy in Secondary Prevention: Results of the SECURE Trial Presenter: Valentin Fuster August 29, 2022 More slides + Presentation ESC 2022 Treatment In the Morning or Evening: The TIME Study Results Presenter: Thomas MacDonald August 29, 2022 Presentation ESC 2022 DANFLU-1 – High-dose vs. standard-dose quadrivalent influenza vaccine in elderly adults Presenter: Niklas Dyrby Johansen August 29, 2022 We Recommend
Presentation ESC 2022 A Polypill Strategy in Secondary Prevention: Results of the SECURE Trial Presenter: Valentin Fuster August 29, 2022
Presentation ESC 2022 Treatment In the Morning or Evening: The TIME Study Results Presenter: Thomas MacDonald August 29, 2022
Presentation ESC 2022 DANFLU-1 – High-dose vs. standard-dose quadrivalent influenza vaccine in elderly adults Presenter: Niklas Dyrby Johansen August 29, 2022